The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history identified no similar complaints from the lot.All available information was investigated, and a cause for the reported slda cannot be determined.Mitral valve insufficiency/ regurgitation appears to be due to the slda of both implanted clips.Mitral regurgitation is listed in the instructions for use (ifu) as a known possible complication associated with mitraclip procedures.Hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.The additional mitraclip device referenced in b5 is being filed under a separate medwatch report.
|
It was reported that on (b)(6) 2023, a mitraclip procedure was performed to treat degenerative mitral regurgitation (mr) with a grade 4.After deployment of the xtw clip, the clip arms opened to roughly 30 degrees.A second clip was then implanted to help stabilize the implanted clip.Mr was reduced to a grade of 1-2.On (b)(6) 2023, the patient returned to the hospital.Echocardiography was performed and showed the two implanted clips had detached from the posterior leaflet and remained attached to the anterior leaflet (single leaflet device attachment/slda), causing mr to increase to a grade of 4.It was also noted one of the grippers of the first clip was noted to be bent.
|